Cite
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection.
MLA
Karismananda, et al. “Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection.” Antibodies (2073-4468), vol. 13, no. 3, Sept. 2024, p. 72. EBSCOhost, https://doi.org/10.3390/antib13030072.
APA
Karismananda, Hasyim, A. A., Sakamoto, A., Yamagata, K., Zainal, K. H., Suparman, D. D. N., Yustisia, I., Hardjo, M., Kadir, S., Iyori, M., Yoshida, S., & Yusuf, Y. (2024). Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection. Antibodies (2073-4468), 13(3), 72. https://doi.org/10.3390/antib13030072
Chicago
Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, Kyouhei Yamagata, Kartika Hardianti Zainal, Desi Dwirosalia Ningsih Suparman, Ika Yustisia, et al. 2024. “Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection.” Antibodies (2073-4468) 13 (3): 72. doi:10.3390/antib13030072.